Dennis Langer, Director at MYRIAD GENETICS INC (MYGN), sold 70,000 shares at $29.82 ($2.1M) on 2012-11-29, disclosed to the SEC on 2012-12-03.
Open-market sale of $2.1M MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.82 | 10,000 | $298K | 14.3% |
| 2 | $29.82 | 15,000 | $447K | 21.4% |
| 3 | $29.89 | 15,000 | $448K | 21.4% |
| 4 | $29.92 | 30,000 | $898K | 42.9% |
| Total | $29.88 avg | 70,000 | $2.1M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-05 | $1.0M | — | Filing → |
| DRNA | SELL | 2018-08-17 | $613K | — | Filing → |
| MYGN | SELL | 2018-06-08 | $1.6M | — | Filing → |